Stocktoria
Seer, Inc. SEER
Nasdaq · stock · Laboratory Analytical Instruments · website · IPO 2020-12-04
Seer, Inc. financials (annual)
Bars are annual figures from 2020 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | $16.6M | $14.2M | $16.7M | $15.5M | $6.6M | $656,000 |
| Gross profit | $8.5M | $7.1M | $8.5M | $7.1M | $3.4M | $656,000 |
| R&D expense | $43.9M | $50.6M | $53.0M | $45.8M | $29.1M | $18.9M |
| SG&A expense | $42.6M | $56.6M | $59.0M | $58.5M | $45.8M | $15.4M |
| Operating income | -$78.0M | -$100.1M | -$103.5M | -$97.2M | -$71.5M | -$33.6M |
| Interest expense | — | — | — | $0 | $22,000 | $0 |
| Income tax | $201,000 | $98,000 | $0 | $0 | $0 | $0 |
| Net income | -$73.6M | -$86.6M | -$86.3M | -$93.0M | -$71.2M | -$32.8M |
| EPS (diluted) | — | — | $-1.35 | $-1.49 | $-1.17 | $-2.48 |
| Operating cash flow | -$44.4M | -$46.1M | -$59.1M | -$60.8M | -$46.3M | -$20.8M |
| Free cash flow | -$46.2M | -$49.7M | -$66.4M | -$71.0M | -$53.3M | -$25.4M |
| Cash & equivalents | $47.3M | $40.8M | $32.5M | $53.2M | $232.8M | $333.6M |
| Inventory | $7.8M | $7.4M | $4.5M | $4.6M | $4.1M | $551,000 |
| Total assets | $296.1M | $366.6M | $436.3M | $487.9M | $539.1M | $442.3M |
| Total liabilities | $36.8M | $39.0M | $39.4M | $40.9M | $36.2M | $10.7M |
| Shareholders' equity | $259.3M | $327.6M | $396.9M | $447.0M | $502.9M | $431.6M |
Growth · year-over-year · Revenue CAGR 90.8%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue growth | +17.0% | -15.0% | +7.5% | +134.1% | +908.7% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.